All open calls

    Advancing innovation in accelerated cancer diagnosis

    Closing soon · 15 daysOfficial United Kingdom government data

    Innovate UK, on behalf of the Office for Life Sciences’ (OLS) (UK) · National scheme · 1 eligible country

    €4.6M
    Published funding
    28 Oct 2026
    Deadline

    What this scheme funds

    This UK programme funds the clinical validation and evaluation of new technologies and devices that detect cancer earlier. Up to 25.4 million pounds is available across all successful applicants to help move early diagnostic innovations closer to real world clinical use.

    diagnostics · digital-health · public-health

    Do you qualify for this scheme?

    Tell us your website and we'll check this scheme's own conditions against what your company does.

    Only the website is required.

    Who it is for

    Organisations from the public, non profit or private sector in the UK developing early cancer diagnostic technologies ready for clinical validation are best suited to this call.

    The scheme in detail

    Agency
    Innovate UK, on behalf of the Office for Life Sciences’ (OLS) (UK)
    Eligible countries (1)
    United Kingdom
    Funding
    €4.6M
    Deadline
    28 Oct 2026
    Applicant type
    Not stated by the agency.
    Eligible applicants
    public body, non-profit, private sector
    Also required
    Total scheme budget of 25.4 million pounds is shared across all recipients, not awarded per applicant.

    Similar open calls